DK0910363T3 - Veterinær anvendelse af et pleuromutilinderivat - Google Patents

Veterinær anvendelse af et pleuromutilinderivat

Info

Publication number
DK0910363T3
DK0910363T3 DK97933652.6T DK97933652T DK0910363T3 DK 0910363 T3 DK0910363 T3 DK 0910363T3 DK 97933652 T DK97933652 T DK 97933652T DK 0910363 T3 DK0910363 T3 DK 0910363T3
Authority
DK
Denmark
Prior art keywords
pleuromutiline
derivative
veterinary use
veterinary
mutlin
Prior art date
Application number
DK97933652.6T
Other languages
English (en)
Inventor
David George Sidney Burch
Paul Howard Ripley
Erich Zeisl
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614018.1A external-priority patent/GB9614018D0/en
Priority claimed from GBGB9614016.5A external-priority patent/GB9614016D0/en
Priority claimed from GBGB9614019.9A external-priority patent/GB9614019D0/en
Priority claimed from GBGB9614013.2A external-priority patent/GB9614013D0/en
Priority claimed from GBGB9614012.4A external-priority patent/GB9614012D0/en
Priority claimed from GBGB9614015.7A external-priority patent/GB9614015D0/en
Priority claimed from GBGB9614014.0A external-priority patent/GB9614014D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of DK0910363T3 publication Critical patent/DK0910363T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97933652.6T 1996-07-04 1997-07-03 Veterinær anvendelse af et pleuromutilinderivat DK0910363T3 (da)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9614018.1A GB9614018D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614016.5A GB9614016D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614017.3A GB9614017D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614019.9A GB9614019D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614013.2A GB9614013D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614012.4A GB9614012D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614015.7A GB9614015D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614014.0A GB9614014D0 (en) 1996-07-04 1996-07-04 Organic compounds
PCT/EP1997/003518 WO1998001127A1 (en) 1996-07-04 1997-07-03 Veterinary use of a pleuromutilin derivative

Publications (1)

Publication Number Publication Date
DK0910363T3 true DK0910363T3 (da) 2011-09-05

Family

ID=27571326

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97933652.6T DK0910363T3 (da) 1996-07-04 1997-07-03 Veterinær anvendelse af et pleuromutilinderivat
DK06127207.6T DK1813272T3 (da) 1996-07-04 1997-07-03 Veterinær anvendelse af et pleuromutilinderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06127207.6T DK1813272T3 (da) 1996-07-04 1997-07-03 Veterinær anvendelse af et pleuromutilinderivat

Country Status (25)

Country Link
US (1) US6130250A (da)
EP (4) EP1813272B1 (da)
JP (1) JP4165769B2 (da)
CN (1) CN1121216C (da)
AT (2) ATE503475T1 (da)
AU (1) AU718701B2 (da)
BG (1) BG64369B1 (da)
BR (1) BR9710208A (da)
CA (1) CA2256514C (da)
CZ (4) CZ298385B6 (da)
DE (1) DE69740162D1 (da)
DK (2) DK0910363T3 (da)
ES (2) ES2360813T3 (da)
GB (1) GB9614017D0 (da)
HU (1) HU230325B1 (da)
IL (1) IL127299A (da)
NO (1) NO326117B1 (da)
NZ (1) NZ333261A (da)
OA (1) OA10951A (da)
PL (1) PL189204B1 (da)
PT (2) PT910363E (da)
RU (1) RU2197237C2 (da)
SK (4) SK285857B6 (da)
UA (1) UA56173C2 (da)
WO (1) WO1998001127A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
TWI228048B (en) * 1999-12-09 2005-02-21 Novartis Ag New formulation
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
US6682762B2 (en) * 2001-10-09 2004-01-27 Heart-O-Dixie Animal Nutrition, Llc Poultry and livestock feed additive
CO5390081A1 (es) * 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
RU2287989C2 (ru) * 2004-02-25 2006-11-27 Общество с ограниченной ответственностью "ВИК-здоровье животных" Препарат для профилактики и лечения заболеваний животных и птиц, вызванных микоплазмами или серпулинами в ассоциации с бактериями
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
DE102006021493B4 (de) * 2006-05-09 2010-04-01 Bruker Daltonik Gmbh Massenspektrometrische Messung mikrobieller Resistenzen
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
CN101690717B (zh) * 2009-09-30 2013-03-06 北京大北农动物保健科技有限责任公司 一种兽用沃尼妙林及其盐的预混剂及制备方法
RU2416431C1 (ru) * 2009-10-16 2011-04-20 Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук Способ лечения респираторных болезней телят
RU2418605C1 (ru) * 2009-10-16 2011-05-20 Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук Способ лечения респираторных болезней телят
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130709A (en) * 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
US4247542A (en) * 1978-06-22 1981-01-27 Eli Lilly And Company A-40104 Antibiotics and process for production thereof
EP0153277B1 (de) * 1984-02-17 1987-08-26 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE3413708A1 (de) * 1984-04-12 1985-10-24 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
AT392272B (de) * 1989-10-03 1991-02-25 Biochemie Gmbh Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
CN1039585C (zh) * 1993-01-01 1998-08-26 生化企业 截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂

Also Published As

Publication number Publication date
OA10951A (en) 2003-02-26
US6130250A (en) 2000-10-10
PT1813272E (pt) 2011-04-29
CA2256514A1 (en) 1998-01-15
IL127299A (en) 2005-05-17
PL189204B1 (pl) 2005-07-29
ATE503475T1 (de) 2011-04-15
DK1813272T3 (da) 2011-07-18
CZ438198A3 (cs) 1999-03-17
AU718701B2 (en) 2000-04-20
IL127299A0 (en) 1999-09-22
AU3692997A (en) 1998-02-02
CZ298444B6 (cs) 2007-10-03
NO986198L (no) 1998-12-30
EP0910363B1 (en) 2011-05-18
BR9710208A (pt) 1999-08-10
HU230325B1 (hu) 2016-02-29
HUP9903103A3 (en) 2000-04-28
EP0910363A1 (en) 1999-04-28
BG103002A (en) 1999-09-30
BG64369B1 (bg) 2004-12-30
CN1121216C (zh) 2003-09-17
CZ298446B6 (cs) 2007-10-03
UA56173C2 (uk) 2003-05-15
HUP9903103A2 (hu) 2000-02-28
SK2799A3 (en) 1999-09-10
NO986198D0 (no) 1998-12-30
EP1810672A1 (en) 2007-07-25
NZ333261A (en) 2000-09-29
ES2360813T3 (es) 2011-06-09
DE69740162D1 (de) 2011-05-12
CZ298385B6 (cs) 2007-09-19
GB9614017D0 (en) 1996-09-04
SK286445B6 (sk) 2008-10-07
SK286431B6 (sk) 2008-10-07
CN1223576A (zh) 1999-07-21
EP1813272B1 (en) 2011-03-30
PT910363E (pt) 2011-05-31
WO1998001127A1 (en) 1998-01-15
RU2197237C2 (ru) 2003-01-27
PL330726A1 (en) 1999-05-24
SK285711B6 (sk) 2007-06-07
ATE509625T1 (de) 2011-06-15
CZ298445B6 (cs) 2007-10-03
JP2000514072A (ja) 2000-10-24
CA2256514C (en) 2006-11-28
JP4165769B2 (ja) 2008-10-15
EP1808171A1 (en) 2007-07-18
EP1813272A1 (en) 2007-08-01
SK285857B6 (sk) 2007-09-06
NO326117B1 (no) 2008-09-29
ES2364414T3 (es) 2011-09-01

Similar Documents

Publication Publication Date Title
DK1813272T3 (da) Veterinær anvendelse af et pleuromutilinderivat
DK1223980T3 (da) Anvendelse af CSF-1-inhibitorer
DE69201948D1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
EA200300544A1 (ru) Эффективные противоопухолевые лекарственные средства
DE69814394D1 (de) Verwendung von levobupivacain
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
SE9101840D0 (sv) New medicinal use
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
ATE339202T1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
NO902157L (no) Butensyrederivater for terapeutisk anvendelse.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
EP1062948A4 (en) DRUGS AGAINST CARDIAC DIASTOLIC DISORDERS
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
SE9602262D0 (sv) New use of derivatives of cystine
RU94044487A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения мужского бесплодия
MXPA02012089A (es) Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos.
DE69228235D1 (de) Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung
PT1307441E (pt) 1,3-dioxolanos com actividade antitussica
ITNA910058V0 (it) Dislocatore, aspiratore, irrigatore per interventi chirurgici addominali